Figure 2D shows that silencing of all 10 candidate p53 pathway inhibitor genes increased luminescence in H292/PG13Luc cells, validating their functional activity in multiple NSCLC cell lines. The gene discussed is TP53; the disease is non-small cell lung carcinoma.